Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritsuko Onuki

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Anticancer Research|April 28, 2026
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial CancerKeita Goto, Kiyohiro Ando, Noriko Motoi, et al.
Oncology Letters|March 20, 2026
Telomere maintenance mechanisms are activated in ganglioneuroblastoma and ganglioneuromaMotoki Sugawara, Masayuki Haruta, Miki Ohira, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|October 3, 2013
Next-generation survey sequencing and the molecular organization of wheat chromosome 6BTsuyoshi Tanaka, Fuminori Kobayashi, Giri Prasad Joshi, et al.
Acta Neuropathologica|February 12, 2026
Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profilesKenji Fujimoto, Mai Honda-Kitahara, Naoko Hattori, et al.
Cancer Science|December 28, 2021
Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1Kotoe Oshima, Ken Kato, Yoshinori Ito, et al.
Cancers|November 26, 2022
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker StudyMotoo Nagane, Koichi Ichimura, Ritsuko Onuki, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Anticancer Research|April 28, 2026
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial CancerKeita Goto, Kiyohiro Ando, Noriko Motoi, et al.
Oncology Letters|March 20, 2026
Telomere maintenance mechanisms are activated in ganglioneuroblastoma and ganglioneuromaMotoki Sugawara, Masayuki Haruta, Miki Ohira, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|October 3, 2013
Next-generation survey sequencing and the molecular organization of wheat chromosome 6BTsuyoshi Tanaka, Fuminori Kobayashi, Giri Prasad Joshi, et al.
Acta Neuropathologica|February 12, 2026
Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profilesKenji Fujimoto, Mai Honda-Kitahara, Naoko Hattori, et al.
Cancer Science|December 28, 2021
Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1Kotoe Oshima, Ken Kato, Yoshinori Ito, et al.
Cancers|November 26, 2022
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker StudyMotoo Nagane, Koichi Ichimura, Ritsuko Onuki, et al.
Pageof 2